DZIF
A German national research centre coordinating translational infectious-disease research across multiple sites. Activities span preclinical and clinical research, cohort and biobank management, diagnostic and therapeutic development (including vaccines, antimicrobials and microbiome-based approaches), pathogen genomics and digital surveillance, and training to accelerate translation of research into clinical practice.
Industries
Nr. of Employees
small (1-50)
DZIF
Geschäftsstelle des DZIF e. V., Inhoffenstraße 7, 38124 Braunschweig, Germany
Products
Open-source digital outbreak-management and surveillance platform
An open-source digital process-management platform for detection, analysis and management of infectious-disease outbreaks, supporting multidirectional data exchange between hospitals, laboratories and public-health authorities and usable on mobile devices including offline scenarios.
Open-source digital outbreak-management and surveillance platform
An open-source digital process-management platform for detection, analysis and management of infectious-disease outbreaks, supporting multidirectional data exchange between hospitals, laboratories and public-health authorities and usable on mobile devices including offline scenarios.
Services
Operational support for multicentre clinical studies including provision of study nurses and coordination across partner sites.
Provision of sequencing capacity and bioinformatic analysis pipelines for translational pathogen surveillance and microbiome research.
Fellowships, travel grants, workshops and courses to support early-career researchers and translational skills development.
Organisation of thematic workshops (e.g., microbiome LBP development, cell and gene therapy, deep learning for genomics) to share methods and advance collaborative projects.
Advisory and deployment support for open-source outbreak-management software, including international collaboration, data integration and mobile/offline deployments.
Operational support for multicentre clinical studies including provision of study nurses and coordination across partner sites.
Provision of sequencing capacity and bioinformatic analysis pipelines for translational pathogen surveillance and microbiome research.
Fellowships, travel grants, workshops and courses to support early-career researchers and translational skills development.
Organisation of thematic workshops (e.g., microbiome LBP development, cell and gene therapy, deep learning for genomics) to share methods and advance collaborative projects.
Advisory and deployment support for open-source outbreak-management software, including international collaboration, data integration and mobile/offline deployments.
Expertise Areas
- Translational infectious-disease research
- Clinical trial management and cohort studies
- Pathogen genomics and molecular epidemiology
- Diagnostic assay development and validation
Key Technologies
- Next-generation sequencing (NGS)
- Whole-genome sequencing (WGS) for pathogens
- Single-cell RNA sequencing
- Multi-omics analysis
News & Updates
Two-day workshop focused on advancing development of live biotherapeutic products and microbial signatures for interventions.
Publication reporting multi-omics and single-cell RNA-seq analysis to define immunotypes and blood-based molecular signatures for extrapulmonary TB diagnosis.
Research article on factors affecting gut colonization resistance, relevant to microbiome and infection research.
A DZIF-funded junior group leader received a European Research Council Starting Grant (€1.5 million) to study Plasmodium falciparum survival during dry seasons.
Epidemiologist Gérard Krause awarded the DZIF prize for contributions to translational infection epidemiology and development of an open-source digital outbreak-management system.
Two-day workshop focused on advancing development of live biotherapeutic products and microbial signatures for interventions.
Publication reporting multi-omics and single-cell RNA-seq analysis to define immunotypes and blood-based molecular signatures for extrapulmonary TB diagnosis.
Research article on factors affecting gut colonization resistance, relevant to microbiome and infection research.
A DZIF-funded junior group leader received a European Research Council Starting Grant (€1.5 million) to study Plasmodium falciparum survival during dry seasons.
Epidemiologist Gérard Krause awarded the DZIF prize for contributions to translational infection epidemiology and development of an open-source digital outbreak-management system.